|
VPS45 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.4130031306413E-11 |
| Normal-vs-Stage3 |
3.33066907387547E-16 |
| Normal-vs-Stage4 |
2.02282635086704E-12 |
| Stage1-vs-Stage2 |
8.185200E-01 |
| Stage1-vs-Stage3 |
4.997200E-01 |
| Stage1-vs-Stage4 |
8.958200E-01 |
| Stage2-vs-Stage3 |
5.044400E-01 |
| Stage2-vs-Stage4 |
9.202400E-01 |
| Stage3-vs-Stage4 |
5.294000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
1.57303999999137E-05 |
| Normal-vs-Asian |
6.362400E-02 |
| Caucasian-vs-AfricanAmerican |
5.804200E-02 |
| Caucasian-vs-Asian |
6.963500E-02 |
| AfricanAmerican-vs-Asian |
5.783400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.74904535299447E-12 |
| Male-vs-Female |
1.637030E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.41579999946018E-07 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.66684999999278E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.166600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.666200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.969400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.282220E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.790000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.776600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.185640E-02 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
1.62458935193399E-12 |
| Normal-vs-Grade 4 |
1.660116488722E-12 |
| Grade 1-vs-Grade 2 |
6.331600E-02 |
| Grade 1-vs-Grade 3 |
4.917600E-02 |
| Grade 1-vs-Grade 4 |
5.295800E-02 |
| Grade 2-vs-Grade 3 |
2.889200E-01 |
| Grade 2-vs-Grade 4 |
7.225000E-01 |
| Grade 3-vs-Grade 4 |
6.666600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
1.6251444634463E-12 |
| ccA subtype-vs-ccB subtype |
7.758400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62436730732907E-12 |
| Normal-vs-N1 |
2.554100E-04 |
| N0-vs-N1 |
4.119000E-01 |
|
|
